StockData
Actuate Therapeutics, Inc. logo

Actuate Therapeutics, Inc. (ACTU) stock

ACTUNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 0/30
$0.25−0.02 (-6.12%)

Close on Nov 17, 2026Market cap $6.04MP/E –Yield –

Actuate Therapeutics total assets

Total assets on the balance sheet at the end of each period.

Actuate Therapeutics's total assets was $3.22M at Sep 30, 2026. For fiscal 2025 it was $14.04M, up 50.6% from the year before.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$14.04M+50.6%
FY2024Dec 31, 2024$9.32M+211.1%
FY2023Dec 31, 2023$3.00M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$3.22M-81.8%
Q2 FY2026Jun 30, 2026$5.20M-25.4%
Q1 FY2026Mar 31, 2026$8.91M+98.8%
Q4 FY2025Dec 31, 2025$14.04M+50.6%
Q3 FY2025Sep 30, 2025$17.71M+24.2%
Q2 FY2025Jun 30, 2025$6.97M+302.6%
Q1 FY2025Mar 31, 2025$4.48M+49.7%
Q4 FY2024Dec 31, 2024$9.32M–
Q3 FY2024Sep 30, 2024$14.26M–
Q2 FY2024Jun 30, 2024$1.73M–
Q4 FY2023Dec 31, 2023$3.00M–

More Actuate Therapeutics figures

See a number that looks wrong?